Free Newsletter
Transgenic chickens used to manufacture proteins
Researchers at the Roslin BioCentre in Scotland have advanced a program to use transgenic chickens to create new drugs for a variety of ailments. By injecting genes for certain proteins into the hen's gene for ovalbumin, a protein that makes up more than half of egg whites, the chickens produced those therapeutic proteins in their egg whites. A new generation of transgenic therapies are in the pipeline, many using goats to create a new way to manufacture meds in their milk. Backers say that using farm animals to develop drugs would be much less expensive than current manufacturing methods.
"With the demand for therapeutic protein drugs increasing, the efficient generation of transgenic hens that produce functional protein drugs at high levels in egg whites marks an important step in the development of this technology," according to a statement released by the Proceedings of the Proceedings of the National Academies of Science, which published the research in its online edition.
- read the report on the chicken research from Xinhuanet
Related Articles:
GTC inks new transgenics collaboration deal. Report
EMEA rejects GTC's therapy from modified goats. Report
Pharming gets orphan status for transgenic therapy. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession





SHARE
WITH: